(1)
THE IMPACT OF TERLIPRESSIN ON HEPATORENEAL DISEASE: RESULTS OF AN OBSERVATIONAL, DESCRIPTIVE, AND CROSS-SECTIONAL STUDY DISEASE. Journal of Pharmaceutical Negative Results 2022, 2320-2326. https://doi.org/10.47750/pnr.2022.13.S04.286.